Global Immunotherapy Market Research Report 2023

The global Immunotherapy market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Immunotherapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Immunotherapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Immunotherapy in Oncology is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Immunotherapy include Abbvie, Amgen, Inc., Biogen, Bristol-Myers Squibb, Celgene, Johnson & Johnson, Merck, Novartis and Pfizer, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunotherapy.

The Immunotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Immunotherapy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Immunotherapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Monoclonal Antibodies

1.2.3 Therapeutic Vaccines

1.2.4 Checkpoint Inhibitors

1.2.5 Non-Specific Immunotherapy

1.3 Market by Application

1.3.1 Global Immunotherapy Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Oncology

1.3.3 Inflammation

1.3.4 Central Nervous System

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Immunotherapy Market Perspective (2018-2029)

2.2 Immunotherapy Growth Trends by Region

2.2.1 Global Immunotherapy Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Immunotherapy Historic Market Size by Region (2018-2023)

2.2.3 Immunotherapy Forecasted Market Size by Region (2024-2029)

2.3 Immunotherapy Market Dynamics

2.3.1 Immunotherapy Industry Trends

2.3.2 Immunotherapy Market Drivers

2.3.3 Immunotherapy Market Challenges

2.3.4 Immunotherapy Market Restraints

3.1 Global Top Immunotherapy Players by Revenue

3.1.1 Global Top Immunotherapy Players by Revenue (2018-2023)

3.1.2 Global Immunotherapy Revenue Market Share by Players (2018-2023)

3.2 Global Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Immunotherapy Revenue

3.4 Global Immunotherapy Market Concentration Ratio

3.4.1 Global Immunotherapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Immunotherapy Revenue in 2022

3.5 Immunotherapy Key Players Head office and Area Served

3.6 Key Players Immunotherapy Product Solution and Service

3.7 Date of Enter into Immunotherapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Immunotherapy Historic Market Size by Type (2018-2023)

4.2 Global Immunotherapy Forecasted Market Size by Type (2024-2029)

5.1 Global Immunotherapy Historic Market Size by Application (2018-2023)

5.2 Global Immunotherapy Forecasted Market Size by Application (2024-2029)

6.1 North America Immunotherapy Market Size (2018-2029)

6.2 North America Immunotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Immunotherapy Market Size by Country (2018-2023)

6.4 North America Immunotherapy Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Immunotherapy Market Size (2018-2029)

7.2 Europe Immunotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Immunotherapy Market Size by Country (2018-2023)

7.4 Europe Immunotherapy Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Immunotherapy Market Size (2018-2029)

8.2 Asia-Pacific Immunotherapy Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Immunotherapy Market Size by Region (2018-2023)

8.4 Asia-Pacific Immunotherapy Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Immunotherapy Market Size (2018-2029)

9.2 Latin America Immunotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Immunotherapy Market Size by Country (2018-2023)

9.4 Latin America Immunotherapy Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Immunotherapy Market Size (2018-2029)

10.2 Middle East & Africa Immunotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Immunotherapy Market Size by Country (2018-2023)

10.4 Middle East & Africa Immunotherapy Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Abbvie

11.1.1 Abbvie Company Detail

11.1.2 Abbvie Business Overview

11.1.3 Abbvie Immunotherapy Introduction

11.1.4 Abbvie Revenue in Immunotherapy Business (2018-2023)

11.1.5 Abbvie Recent Development

11.2 Amgen, Inc.

11.2.1 Amgen, Inc. Company Detail

11.2.2 Amgen, Inc. Business Overview

11.2.3 Amgen, Inc. Immunotherapy Introduction

11.2.4 Amgen, Inc. Revenue in Immunotherapy Business (2018-2023)

11.2.5 Amgen, Inc. Recent Development

11.3 Biogen

11.3.1 Biogen Company Detail

11.3.2 Biogen Business Overview

11.3.3 Biogen Immunotherapy Introduction

11.3.4 Biogen Revenue in Immunotherapy Business (2018-2023)

11.3.5 Biogen Recent Development

11.4 Bristol-Myers Squibb

11.4.1 Bristol-Myers Squibb Company Detail

11.4.2 Bristol-Myers Squibb Business Overview

11.4.3 Bristol-Myers Squibb Immunotherapy Introduction

11.4.4 Bristol-Myers Squibb Revenue in Immunotherapy Business (2018-2023)

11.4.5 Bristol-Myers Squibb Recent Development

11.5 Celgene

11.5.1 Celgene Company Detail

11.5.2 Celgene Business Overview

11.5.3 Celgene Immunotherapy Introduction

11.5.4 Celgene Revenue in Immunotherapy Business (2018-2023)

11.5.5 Celgene Recent Development

11.6 Johnson & Johnson

11.6.1 Johnson & Johnson Company Detail

11.6.2 Johnson & Johnson Business Overview

11.6.3 Johnson & Johnson Immunotherapy Introduction

11.6.4 Johnson & Johnson Revenue in Immunotherapy Business (2018-2023)

11.6.5 Johnson & Johnson Recent Development

11.7 Merck

11.7.1 Merck Company Detail

11.7.2 Merck Business Overview

11.7.3 Merck Immunotherapy Introduction

11.7.4 Merck Revenue in Immunotherapy Business (2018-2023)

11.7.5 Merck Recent Development

11.8 Novartis

11.8.1 Novartis Company Detail

11.8.2 Novartis Business Overview

11.8.3 Novartis Immunotherapy Introduction

11.8.4 Novartis Revenue in Immunotherapy Business (2018-2023)

11.8.5 Novartis Recent Development

11.9 Pfizer

11.9.1 Pfizer Company Detail

11.9.2 Pfizer Business Overview

11.9.3 Pfizer Immunotherapy Introduction

11.9.4 Pfizer Revenue in Immunotherapy Business (2018-2023)

11.9.5 Pfizer Recent Development

11.10 Roche

11.10.1 Roche Company Detail

11.10.2 Roche Business Overview

11.10.3 Roche Immunotherapy Introduction

11.10.4 Roche Revenue in Immunotherapy Business (2018-2023)

11.10.5 Roche Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Immunotherapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Monoclonal Antibodies

    Table 3. Key Players of Therapeutic Vaccines

    Table 4. Key Players of Checkpoint Inhibitors

    Table 5. Key Players of Non-Specific Immunotherapy

    Table 6. Global Immunotherapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Immunotherapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Immunotherapy Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Immunotherapy Market Share by Region (2018-2023)

    Table 10. Global Immunotherapy Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Immunotherapy Market Share by Region (2024-2029)

    Table 12. Immunotherapy Market Trends

    Table 13. Immunotherapy Market Drivers

    Table 14. Immunotherapy Market Challenges

    Table 15. Immunotherapy Market Restraints

    Table 16. Global Immunotherapy Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Immunotherapy Market Share by Players (2018-2023)

    Table 18. Global Top Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapy as of 2022)

    Table 19. Ranking of Global Top Immunotherapy Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Immunotherapy Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Immunotherapy Product Solution and Service

    Table 23. Date of Enter into Immunotherapy Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Immunotherapy Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Immunotherapy Revenue Market Share by Type (2018-2023)

    Table 27. Global Immunotherapy Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Immunotherapy Revenue Market Share by Type (2024-2029)

    Table 29. Global Immunotherapy Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Immunotherapy Revenue Market Share by Application (2018-2023)

    Table 31. Global Immunotherapy Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Immunotherapy Revenue Market Share by Application (2024-2029)

    Table 33. North America Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Immunotherapy Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Immunotherapy Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Immunotherapy Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Immunotherapy Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Immunotherapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Immunotherapy Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Immunotherapy Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Immunotherapy Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Immunotherapy Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Immunotherapy Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Immunotherapy Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Abbvie Company Detail

    Table 49. Abbvie Business Overview

    Table 50. Abbvie Immunotherapy Product

    Table 51. Abbvie Revenue in Immunotherapy Business (2018-2023) & (US$ Million)

    Table 52. Abbvie Recent Development

    Table 53. Amgen, Inc. Company Detail

    Table 54. Amgen, Inc. Business Overview

    Table 55. Amgen, Inc. Immunotherapy Product

    Table 56. Amgen, Inc. Revenue in Immunotherapy Business (2018-2023) & (US$ Million)

    Table 57. Amgen, Inc. Recent Development

    Table 58. Biogen Company Detail

    Table 59. Biogen Business Overview

    Table 60. Biogen Immunotherapy Product

    Table 61. Biogen Revenue in Immunotherapy Business (2018-2023) & (US$ Million)

    Table 62. Biogen Recent Development

    Table 63. Bristol-Myers Squibb Company Detail

    Table 64. Bristol-Myers Squibb Business Overview

    Table 65. Bristol-Myers Squibb Immunotherapy Product

    Table 66. Bristol-Myers Squibb Revenue in Immunotherapy Business (2018-2023) & (US$ Million)

    Table 67. Bristol-Myers Squibb Recent Development

    Table 68. Celgene Company Detail

    Table 69. Celgene Business Overview

    Table 70. Celgene Immunotherapy Product

    Table 71. Celgene Revenue in Immunotherapy Business (2018-2023) & (US$ Million)

    Table 72. Celgene Recent Development

    Table 73. Johnson & Johnson Company Detail

    Table 74. Johnson & Johnson Business Overview

    Table 75. Johnson & Johnson Immunotherapy Product

    Table 76. Johnson & Johnson Revenue in Immunotherapy Business (2018-2023) & (US$ Million)

    Table 77. Johnson & Johnson Recent Development

    Table 78. Merck Company Detail

    Table 79. Merck Business Overview

    Table 80. Merck Immunotherapy Product

    Table 81. Merck Revenue in Immunotherapy Business (2018-2023) & (US$ Million)

    Table 82. Merck Recent Development

    Table 83. Novartis Company Detail

    Table 84. Novartis Business Overview

    Table 85. Novartis Immunotherapy Product

    Table 86. Novartis Revenue in Immunotherapy Business (2018-2023) & (US$ Million)

    Table 87. Novartis Recent Development

    Table 88. Pfizer Company Detail

    Table 89. Pfizer Business Overview

    Table 90. Pfizer Immunotherapy Product

    Table 91. Pfizer Revenue in Immunotherapy Business (2018-2023) & (US$ Million)

    Table 92. Pfizer Recent Development

    Table 93. Roche Company Detail

    Table 94. Roche Business Overview

    Table 95. Roche Immunotherapy Product

    Table 96. Roche Revenue in Immunotherapy Business (2018-2023) & (US$ Million)

    Table 97. Roche Recent Development

    Table 98. Research Programs/Design for This Report

    Table 99. Key Data Information from Secondary Sources

    Table 100. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Immunotherapy Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Immunotherapy Market Share by Type: 2022 VS 2029

    Figure 3. Monoclonal Antibodies Features

    Figure 4. Therapeutic Vaccines Features

    Figure 5. Checkpoint Inhibitors Features

    Figure 6. Non-Specific Immunotherapy Features

    Figure 7. Global Immunotherapy Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Immunotherapy Market Share by Application: 2022 VS 2029

    Figure 9. Oncology Case Studies

    Figure 10. Inflammation Case Studies

    Figure 11. Central Nervous System Case Studies

    Figure 12. Others Case Studies

    Figure 13. Immunotherapy Report Years Considered

    Figure 14. Global Immunotherapy Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Immunotherapy Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Immunotherapy Market Share by Region: 2022 VS 2029

    Figure 17. Global Immunotherapy Market Share by Players in 2022

    Figure 18. Global Top Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapy as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Immunotherapy Revenue in 2022

    Figure 20. North America Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Immunotherapy Market Share by Country (2018-2029)

    Figure 22. United States Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Immunotherapy Market Share by Country (2018-2029)

    Figure 26. Germany Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Immunotherapy Market Share by Region (2018-2029)

    Figure 34. China Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Immunotherapy Market Share by Country (2018-2029)

    Figure 42. Mexico Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Immunotherapy Market Share by Country (2018-2029)

    Figure 46. Turkey Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Abbvie Revenue Growth Rate in Immunotherapy Business (2018-2023)

    Figure 49. Amgen, Inc. Revenue Growth Rate in Immunotherapy Business (2018-2023)

    Figure 50. Biogen Revenue Growth Rate in Immunotherapy Business (2018-2023)

    Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Immunotherapy Business (2018-2023)

    Figure 52. Celgene Revenue Growth Rate in Immunotherapy Business (2018-2023)

    Figure 53. Johnson & Johnson Revenue Growth Rate in Immunotherapy Business (2018-2023)

    Figure 54. Merck Revenue Growth Rate in Immunotherapy Business (2018-2023)

    Figure 55. Novartis Revenue Growth Rate in Immunotherapy Business (2018-2023)

    Figure 56. Pfizer Revenue Growth Rate in Immunotherapy Business (2018-2023)

    Figure 57. Roche Revenue Growth Rate in Immunotherapy Business (2018-2023)

    Figure 58. Bottom-up and Top-down Approaches for This Report

    Figure 59. Data Triangulation

    Figure 60. Key Executives Interviewed